190.74MMarket Cap-792P/E (TTM)
10.1000High9.1100Low798.70KVolume9.6000Open9.3900Pre Close7.54MTurnover6.82%Turnover RatioLossP/E (Static)20.75MShares29.700052wk High2.29P/B107.70MFloat Cap7.400052wk Low--Dividend TTM11.72MShs Float624.8000Historical High--Div YieldTTM10.54%Amplitude5.3100Historical Low9.4380Avg Price1Lot Size
Adverum Biotechnologies Stock Forum
NEWS
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
Update
4 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and maintenance of both visual acuity and anatomic endpoints –
– Preliminary safety data support a favorable benefit-risk pr...
Sold half at 1.8 but chart look good
Just I am afriad the 1.2 private offering deal (typically 20% to 10% off to fair value) will pin the price to 1.4 to 1.6 area. Cashless warrant is bad for common investors. Also attract too many day traders. won’t last l...
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
feels like insider action.
No comment yet